RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 175.30
-2.60 (-1.46%)
Jul 21, 2026, 1:44 PM CET
RaySearch Laboratories AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 439.3 | 407.3 | 462.7 | 343.68 | 160.27 | 102.54 |
Cash & Short-Term Investments | 439.3 | 407.3 | 462.7 | 343.68 | 160.27 | 102.54 |
Cash Growth | -12.73% | -11.97% | 34.63% | 114.44% | 56.31% | -39.24% |
Accounts Receivable | 448.9 | 473.9 | 444.8 | 383.73 | 370.57 | 317.36 |
Other Receivables | 72.2 | 19.9 | 23.3 | 30.07 | 27.7 | 40.81 |
Total Trade Receivables | 521.1 | 493.8 | 468.1 | 413.79 | 398.26 | 358.17 |
Inventory | 49 | 22 | 10.6 | 9.32 | 14.09 | 29.99 |
Other Current Assets | - | 47.7 | 43.3 | 35.65 | 55.3 | 25.68 |
Total Current Assets | 1,009 | 970.7 | 984.7 | 802.45 | 627.92 | 516.37 |
Net Property, Plant & Equipment | 430.3 | 383.9 | 456.6 | 500.78 | 540.21 | 540.19 |
Other Intangible Assets | 576.5 | - | - | - | - | - |
Other Long-Term Assets | 11.4 | 15.4 | 31.6 | 29.35 | 80.3 | 38.73 |
Total Assets | 2,028 | 1,992 | 2,091 | 1,953 | 1,876 | 1,745 |
Accounts Payable | 26.9 | 35.4 | 38.8 | 42.09 | 24.03 | 48.77 |
Accrued Expenses | - | 65.2 | 57.5 | 41.72 | 50.71 | 385.91 |
Current Portion of Long-Term Debt | - | - | - | - | - | 70.38 |
Current Portion of Leases | 78.5 | 77.5 | 77.1 | 97.38 | 81.31 | - |
Unearned Revenue | 358.3 | 355.9 | 454.2 | 461.14 | 460.71 | - |
Other Current Liabilities | 99.5 | 35.8 | 76.4 | 32.73 | 20.34 | 11.69 |
Total Current Liabilities | 563.2 | 569.9 | 703.8 | 675.05 | 637.1 | 516.75 |
Long-Term Debt | - | - | - | - | - | 491.02 |
Long-Term Leases | 298.8 | 317.3 | 394.9 | 431.98 | 474.08 | - |
Other Long-Term Liabilities | 122.8 | 119.5 | 115.8 | 110.41 | 107.62 | 108.66 |
Total Long-Term Liabilities | 421.7 | 436.8 | 510.7 | 542.39 | 581.7 | 599.68 |
Total Liabilities | 984.9 | 1,007 | 1,215 | 1,217 | 1,219 | 1,116 |
Common Stock | - | 17.1 | 17.1 | 17.14 | 17.14 | 17.14 |
Additional Paid-in Capital | - | 2 | 2 | 1.98 | 1.98 | 1.98 |
Accumulated Other Comprehensive Income | - | -15.8 | 0.7 | -5.87 | -2.37 | -7.44 |
Retained Earnings | - | 982 | 856.9 | 721.98 | 640.41 | 616.63 |
Total Common Shareholders' Equity | - | 985.3 | 876.7 | 735.23 | 657.16 | 628.31 |
Shareholders' Equity | 1,043 | 985.3 | 876.7 | 735.23 | 657.16 | 628.31 |
Total Liabilities & Equity | 2,028 | 1,992 | 2,091 | 1,953 | 1,876 | 1,745 |
Total Debt | 377.3 | 394.8 | 472 | 529.36 | 555.39 | 561.4 |
Net Cash (Debt) | 62 | 12.5 | -9.3 | -185.68 | -395.12 | -458.86 |
Net Cash Growth | 396.00% | - | - | - | - | - |
Net Cash Per Share | 1.81 | 0.36 | -0.27 | -5.42 | -11.53 | -13.38 |
Book Value | - | 985.3 | 876.7 | 735.23 | 657.16 | 628.31 |
Book Value Per Share | - | 28.74 | 25.57 | 21.45 | 19.17 | 18.33 |
Tangible Book Value | -576.5 | 985.3 | 876.7 | 735.23 | 657.16 | 628.31 |
Tangible Book Value Per Share | -16.82 | 28.74 | 25.57 | 21.45 | 19.17 | 18.33 |